Feb 21, 2018 7:00 am EST NeoGenomics Reports Revenue of $67.8 Million on 18.7% Clinical Volume Growth and $10.5 Million of Adjusted EBITDA in the Fourth Quarter of 2017
Jan 30, 2018 7:00 am EST NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2017 Earnings Release for February 21, 2018
Dec 6, 2017 7:00 am EST NeoGenomics Announces Six Clinical Data Presentations to be Made at the American Society of Hematology Meeting
Dec 5, 2017 7:00 am EST NeoGenomics Joins Thermo Fisher Scientific's Companion Diagnostic Center of Excellence Program with the Launch of Oncomine Dx Target Test
Nov 9, 2017 7:00 am EST NeoGenomics Europe S.A. Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials
Oct 25, 2017 7:00 am EDT NeoGenomics Reports Revenue of $63.1 Million on 17% Volume Growth and 11% Reduction in Average Cost per Test in the Third Quarter of 2017
Oct 24, 2017 9:00 am EDT NeoGenomics Announces the Opening of its First International Laboratory near Geneva, Switzerland to Support Clinical Trials
Oct 12, 2017 4:01 pm EDT NeoGenomics Announces Preliminary Quarter 3 Results, Financial Impacts of Hurricanes and Summary Quarter 4 Guidance
